trial

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

In Wine There Is Truth

By: Katharine Cimmino, Editor-in-Chief - Many articles and quick one-line stories have been cropping up on the internet boasting the…

12 years ago

HIV Pre-Exposure Prophylaxis

By: Elissa Tam PharmD Candidate c/o 2015 - HIV/AIDS continues to be a persistent problem in the United States and…

12 years ago

Reservoir of Migraine Therapies Includes Analgesics, AEDs, and now Monoclonal Antibodies

By Davidta Brown, Senior Staff Editor - The pain, nausea, and light or sound sensitivity that comprise a migraine attack…

12 years ago

Migraine Relief at the Push of a Button

By: Davidta Brown, Senior Staff Editor - A new therapeutic device has seemingly leapt from the pages of a science…

12 years ago

Quantifying the Benefits of Pharmacist Prescribing Power

By Davidta Brown, Senior Staff Editor - The idea of granting pharmacists the right to prescribe, as well as to…

12 years ago

Grastek®: FDA Approves New Sublingual Immunotherapy for Allergies

By: Kevin Lin, PharmD Candidate c/o 2015 - This April, the FDA approved three sublingual immunotherapies for pollen induced allergic…

12 years ago

Scientists Finally Discover How HIV Progresses to AIDS

By: Sabrina Ahmed, PharmD Candidate c/o 2017 - Over the decades, one of the biggest mysteries encountered by researchers has…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

The Use of Topical Opioid Treatment for Pressure Ulcer Wounds

By: Katharine Cimmino, Editor-in-Chief - Pressure ulcers can be a painful condition decreasing the quality of life of patients and…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

Low Literacy and Medication Management?

By: Jenny Park, Pharm. D. Candidate c/o 2015 - As the Affordable Care Act brings health care to many people…

12 years ago

Dengue Fever: Where Do We Go From Here?

By: Sherin Pathickal, PharmD Candidate c/o 2016 - Dengue Fever, widely known as “break-bone fever,” is an illness that causes…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

The Blunt Truth

By: Katharine Cimmino, Editor-in-Chief - Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a…

12 years ago

Direct Association of HIV and Early Kidney Damage in Women

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…

12 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Possible Mandatory Lung Cancer Screening

By: Jenny Park, PharmD Candidate c/o 2015 - Lung cancer takes away the lives of about 160,000 individuals annually, which…

13 years ago

Advancements Towards a Malaria Vaccine

By: Sang Hyo Kim, Staff Editor - A new experimental vaccine, PfsPZ, offers great promise as a cure for malaria.…

13 years ago

New Treatment for a Deficiency in Iron-Supplement Therapies

By: Davidta Brown, Staff Editor - For the estimated 7.5 million individuals in the United States living with iron deficiency…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

Hope For Children with Acute Lymphoblastic Leukemia

By: Ada Seldin, Staff Editor - Emily Whitehead, a 7-year-old girl who fought off relapsing acute lymphoblastic leukemia (ALL), has…

13 years ago

Nattokinase use in DVT prophylaxis

Samad Tirmizi, Pharm. D. Candidate c/o 2014 - Deep vein thrombosis (DVT) is a clot formation that occurs within deep…

13 years ago

A Close Concurrence on Certolizumab (Cimzia®)

By: Sang Hyo Kim, Staff Editor - This year, on July 23rd, FDA advisers voted 7 to 6, with one…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Angelina Jolie’s Double Mastectomy: What it Reveals About Today’s Genetic Testing & Road to Curing Breast Cancer

By Sang Hyo Kim, Staff Editor - Angelina Jolie, the actress recognized for her charismatic beauty, revealed to the New…

13 years ago

Helping Solve the Cruel Mystery

By: Erica Dimitropoulos, Senior Staff Editor - Lupus is highly unpredictable and occurs without warning; there is no known cause…

13 years ago

Pay to Delay: The Honest Truth

By: David Ong, Pharm.D. Candidate c/o 2014 - Our current healthcare system receives much criticism from the press as well…

13 years ago

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago

Disclosure of Clinical Research Funding: Can Ignorance be Bliss?

By: Bharat Kirthivasan, Co-Copy Editor [Content-Focused] - Most people would prefer that a research paper be mandated to disclose its…

13 years ago

Regulation of Low to Moderate Risk Medical Devices by the Food and Drug Administration

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On March 22, 2013, Public Broadcasting Service (PBS) aired an episode of “Need…

13 years ago

Merck Settles Lawsuits Over Vytorin

By: Tasnima Nabi, Staff Editor - Merck & Co. will pay $688 million to settle two lawsuits filed in December…

13 years ago

Increased Costs of Treatment due to the DSM-V: Implications for Pharmacy Practice

By: James W. Schurr and David Gao, PharmD Candidates 2014 - A recent Op-ed in Newsday by Allen Frances, MD…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

Liraglutide (Victoza®) for Type 2 Diabetes Mellitus

By:  Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…

13 years ago

Emerging Pathways For Treating Hepatitis C Virus

By:  Maria Sorbera, PharmD Candidate c/o 2013, AMSCOP, LIU - Hepatitis C is the leading cause of chronic liver disease…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Safety and Efficacy of Atropine for Salivary Hypersecretion

By: Elsa Thomas, PharmD Candidate c/o 2013 - Atropine is an anticholinergic used to treat various conditions, such as bradycardia,…

14 years ago

New Drug Review: Tofacitinib (Xeljanz®)

By: Jessica Lee, PharmD Candidate c/o 2013 - Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system…

14 years ago

Low-dose SSRIs for the Overly Sensitive Esophagus

By Sunhae Chang, PharmD Candidate c/o 2013 - When patients complain of heartburn, the blame usually shifts to gastroesophageal reflux…

14 years ago

Duloxetine’s Effect on Blood Glucose Levels

By: Neal Shah, Co-Editor-in-Chief - Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US…

14 years ago

The Role of NMDA in Electroconvulsive Therapy and Other Neuropsychological Disorders

By: Neal Shah, Co-Editor-in-Chief - Electroconvulsive therapy (ECT) is a last-line procedure in the treatment of refractory depression, among other…

14 years ago

Bisphosphonates and Atypical Fracture Risk

By: Steve Soman, Pharm.D. Candidate c/o 2013 - Bisphosphonates are proven to enhance bone density and reduce fracture incidence in…

14 years ago

Antiplatelet Use Following Acute Coronary Syndromes

By: Addolorata Ciccone, Co-Copy Editor - Acute Coronary Syndromes Acute coronary syndrome (ACS) is a myocardial ischemia caused by obstruction…

14 years ago